Greece - Buy the Di...
Health Care: Drugs
Exact Sciences Corporation (EXAS: NASDAQ)
$9.15 -0.17 | -1.82%
02/09/12 - 04:00 PM ET
186.70K / 638.10K
Vol / Avg. Vol:9.36 / 9.32
Open / Prev. Close:9.14 - 9.36
Today's Range:4.91 - 9.79
52 Wk Range:14.78%
Performance YTD:TheStreet Rating:
Portfolios with EXAS
- Portfolio NameUser Type
- Contributor8 Health Care Stocks With R...
- Usergdean1
- Userradforj John's SEP & Ta...
- UserBlind Rookie
- Userbbrads Portfolio 1
- Userremodelit Portfolio 1
- UserGoBears Under $5 Stock Picks
- UserMornan
- Userjwpao Portfolio 1
- Userhover Portfolio 1
Latest EXAS Headlines from TheStreet
- Look to Exact Sciences, Not Radient Pharma, for Best Colon Cancer Screen Test 01.23.12 | 01:01 pm
- Biotech Stock Mailbag: YM Bio, Exact, Peregrine 12.09.11 | 06:12 am
- Exact Sciences Corporation (EXAS): CORRECTION 10.06.11 | 04:10 pm
- Exact Sciences' Colon Cancer Screening Trial 07.12.11 | 08:07 am
- 8 Health Care Stocks With Recent Gains 06.29.11 | 02:06 pm
- Biotech Stock Mailbag: Neoprobe 05.06.11 | 07:05 am
- Radient Pharma Readies Onko-Sure Data 03.29.11 | 02:03 pm
- Mayo Clinic Denies Test Link to Radient Pharma 03.07.11 | 05:03 pm
- Biotech Stock Mailbag: Exact Sciences 02.25.11 | 07:02 am
- BIO CEO Conference Live Blog 02.14.11 | 02:02 pm
Press Releases for EXAS
- Time For Exact Sciences Presentation At UBS Healthcare Services Conference Revised - Business Wire 02.06.12 | 11:02 am
- Exact Sciences To Participate In February Investor Conferences - Business Wire 01.30.12 | 04:01 pm
- Exact Sciences To Present At Biotech Showcase 2012 - Business Wire 01.04.12 | 04:01 pm
- Exact Sciences Announces Successful Completion Of Public Offering Of Common Stock - Business Wire 12.09.11 | 01:12 pm
- Exact Sciences Prices Public Offering Of Common Stock - Business Wire 12.06.11 | 08:12 am
- Exact Sciences Announces Proposed Public Offering Of Common Stock - Business Wire 12.05.11 | 04:12 pm
- Exact Sciences To Present At Piper Jaffray Healthcare Conference - Business Wire 11.23.11 | 12:11 pm
- Exact Sciences To Participate In Upcoming Investor Conferences - Business Wire 11.09.11 | 12:11 pm
- Exact Sciences Reports Third-Quarter 2011 Financial Results - Business Wire 11.03.11 | 07:11 am
- Exact Sciences To Host Third-Quarter 2011 Results Webcast And Call - Business Wire 10.24.11 | 12:10 pm
Partner Headlines for EXAS
- 10 Undervalued Biotech Stocks With Insider Buying - Seeking Alpha 06.23.11 | 06:06 am
- Momentum Ideas: Friday's High Volume Gainers Chased by Big Money Managers - Seeking Alpha 04.17.11 | 07:04 am
- Cramer's Mad Money - 6 Earnings and IPOs to Watch for the Coming Week (4/8/11) - Seeking Alpha 04.10.11 | 04:04 am
- Life Science Portfolios: Reflecting on a Year of Out-Performance - Seeking Alpha 12.29.10 | 05:12 am
- UPDATE1-New colon cancer test works without colonoscopy - Reuters 10.28.10 | 05:10 pm
- Detecting More Upside Potential for EXACT Sciences - Seeking Alpha 10.22.10 | 09:10 pm
- Piper Jaffray’s Top Picks for The Second Half of 2010 (CPHD, EXAS, GNMK) - Benzinga 08.24.10 | 09:08 am
- 6 Ways to Trade FDA and Clinical Trial News - Seeking Alpha 05.28.10 | 02:05 pm
